Cargando…

Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis

Background: The viral shedding time (VST) of SARS-CoV-2 mainly determines its transmission and duration of infectiousness. However, it was heterogeneous in the existing studies. Here, we performed a meta-analysis to comprehensively summarize the VST of SARS-CoV-2. Methods: We searched PubMed, Web of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Danying, Zhang, Xiaobao, Chen, Can, Jiang, Daixi, Liu, Xiaoxiao, Zhou, Yuqing, Huang, Chenyang, Zhou, Yiyi, Guan, Zhou, Ding, Cheng, Chen, Lu, Lan, Lei, Fu, Xiaofang, Wu, Jie, Li, Lanjuan, Yang, Shigui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017277/
https://www.ncbi.nlm.nih.gov/pubmed/33816427
http://dx.doi.org/10.3389/fpubh.2021.652842
_version_ 1783674030936555520
author Yan, Danying
Zhang, Xiaobao
Chen, Can
Jiang, Daixi
Liu, Xiaoxiao
Zhou, Yuqing
Huang, Chenyang
Zhou, Yiyi
Guan, Zhou
Ding, Cheng
Chen, Lu
Lan, Lei
Fu, Xiaofang
Wu, Jie
Li, Lanjuan
Yang, Shigui
author_facet Yan, Danying
Zhang, Xiaobao
Chen, Can
Jiang, Daixi
Liu, Xiaoxiao
Zhou, Yuqing
Huang, Chenyang
Zhou, Yiyi
Guan, Zhou
Ding, Cheng
Chen, Lu
Lan, Lei
Fu, Xiaofang
Wu, Jie
Li, Lanjuan
Yang, Shigui
author_sort Yan, Danying
collection PubMed
description Background: The viral shedding time (VST) of SARS-CoV-2 mainly determines its transmission and duration of infectiousness. However, it was heterogeneous in the existing studies. Here, we performed a meta-analysis to comprehensively summarize the VST of SARS-CoV-2. Methods: We searched PubMed, Web of Science, MedRxiv, BioRxiv, CNKI, CSTJ, and Wanfang up to October 25, 2020, for studies that reported VSTs of SARS-CoV-2. Pooled estimates and 95% CIs for the VSTs were calculated using log-transformed data. The VSTs in SARS-CoV-2 infections based on different demographic and clinical characteristics, treatments and specimens were stratified by subgroup analysis. Results: A total of 35 studies involving 3,385 participants met the inclusion criteria. The pooled mean VST was 16.8 days (95% CI: 14.8–19.4, I(2) = 99.56%) in SARS-CoV-2 infections. The VST was significantly longer in symptomatic infections (19.7 days, 95% CI: 17.2–22.7, I(2) = 99.34%) than in asymptomatic infections (10.9 days, 95% CI: 8.3–14.3, I(2) = 98.89%) (P < 0.05). The VST was 23.2 days (95% CI: 19.0–28.4, I(2) = 99.24%) in adults, which was significantly longer than that in children (9.9 days, 95% CI: 8.1–12.2, I(2) = 85.74%) (P < 0.05). The VST was significantly longer in persons with chronic diseases (24.2 days, 95% CI: 19.2–30.2, I(2) = 84.07%) than in those without chronic diseases (11.5 days, 95% CI: 5.3–25.0, I(2) = 82.11%) (P < 0.05). Persons receiving corticosteroid treatment (28.3 days, 95% CI: 25.6–31.2, I(2) = 0.00%) had a longer VST than those without corticosteroid treatment (16.2 days, 95% CI: 11.5–22.5, I(2) = 92.27%) (P = 0.06). The VST was significantly longer in stool specimens (30.3 days, 95% CI: 23.1–39.2, I(2) = 92.09%) than in respiratory tract specimens (17.5 days, 95% CI: 14.9–20.6, I(2) = 99.67%) (P < 0.05). Conclusions: A longer VST was found in symptomatic infections, infected adults, persons with chronic diseases, and stool specimens.
format Online
Article
Text
id pubmed-8017277
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80172772021-04-03 Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis Yan, Danying Zhang, Xiaobao Chen, Can Jiang, Daixi Liu, Xiaoxiao Zhou, Yuqing Huang, Chenyang Zhou, Yiyi Guan, Zhou Ding, Cheng Chen, Lu Lan, Lei Fu, Xiaofang Wu, Jie Li, Lanjuan Yang, Shigui Front Public Health Public Health Background: The viral shedding time (VST) of SARS-CoV-2 mainly determines its transmission and duration of infectiousness. However, it was heterogeneous in the existing studies. Here, we performed a meta-analysis to comprehensively summarize the VST of SARS-CoV-2. Methods: We searched PubMed, Web of Science, MedRxiv, BioRxiv, CNKI, CSTJ, and Wanfang up to October 25, 2020, for studies that reported VSTs of SARS-CoV-2. Pooled estimates and 95% CIs for the VSTs were calculated using log-transformed data. The VSTs in SARS-CoV-2 infections based on different demographic and clinical characteristics, treatments and specimens were stratified by subgroup analysis. Results: A total of 35 studies involving 3,385 participants met the inclusion criteria. The pooled mean VST was 16.8 days (95% CI: 14.8–19.4, I(2) = 99.56%) in SARS-CoV-2 infections. The VST was significantly longer in symptomatic infections (19.7 days, 95% CI: 17.2–22.7, I(2) = 99.34%) than in asymptomatic infections (10.9 days, 95% CI: 8.3–14.3, I(2) = 98.89%) (P < 0.05). The VST was 23.2 days (95% CI: 19.0–28.4, I(2) = 99.24%) in adults, which was significantly longer than that in children (9.9 days, 95% CI: 8.1–12.2, I(2) = 85.74%) (P < 0.05). The VST was significantly longer in persons with chronic diseases (24.2 days, 95% CI: 19.2–30.2, I(2) = 84.07%) than in those without chronic diseases (11.5 days, 95% CI: 5.3–25.0, I(2) = 82.11%) (P < 0.05). Persons receiving corticosteroid treatment (28.3 days, 95% CI: 25.6–31.2, I(2) = 0.00%) had a longer VST than those without corticosteroid treatment (16.2 days, 95% CI: 11.5–22.5, I(2) = 92.27%) (P = 0.06). The VST was significantly longer in stool specimens (30.3 days, 95% CI: 23.1–39.2, I(2) = 92.09%) than in respiratory tract specimens (17.5 days, 95% CI: 14.9–20.6, I(2) = 99.67%) (P < 0.05). Conclusions: A longer VST was found in symptomatic infections, infected adults, persons with chronic diseases, and stool specimens. Frontiers Media S.A. 2021-03-19 /pmc/articles/PMC8017277/ /pubmed/33816427 http://dx.doi.org/10.3389/fpubh.2021.652842 Text en Copyright © 2021 Yan, Zhang, Chen, Jiang, Liu, Zhou, Huang, Zhou, Guan, Ding, Chen, Lan, Fu, Wu, Li and Yang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Yan, Danying
Zhang, Xiaobao
Chen, Can
Jiang, Daixi
Liu, Xiaoxiao
Zhou, Yuqing
Huang, Chenyang
Zhou, Yiyi
Guan, Zhou
Ding, Cheng
Chen, Lu
Lan, Lei
Fu, Xiaofang
Wu, Jie
Li, Lanjuan
Yang, Shigui
Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis
title Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis
title_full Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis
title_fullStr Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis
title_full_unstemmed Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis
title_short Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis
title_sort characteristics of viral shedding time in sars-cov-2 infections: a systematic review and meta-analysis
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017277/
https://www.ncbi.nlm.nih.gov/pubmed/33816427
http://dx.doi.org/10.3389/fpubh.2021.652842
work_keys_str_mv AT yandanying characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT zhangxiaobao characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT chencan characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT jiangdaixi characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT liuxiaoxiao characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT zhouyuqing characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT huangchenyang characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT zhouyiyi characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT guanzhou characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT dingcheng characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT chenlu characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT lanlei characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT fuxiaofang characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT wujie characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT lilanjuan characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis
AT yangshigui characteristicsofviralsheddingtimeinsarscov2infectionsasystematicreviewandmetaanalysis